Hart Biologicals to attend Medica  Image
Back to Hart Beat

The Hart Of The Industry

Hart Biologicals to attend Medica

By Hart Bio | 12th November 2019
Hart Biologicals to attend Medica  Image

Hart Biologicals will be attending Medica, the leading International Trade Fair and World Forum for Medicine, where more than 5,000 exhibitors will present their newest products and ideas from 18 to 21 November 2019. 

Hart Bio’s Key Account Manager, Jack Doyle, will be attending the trade fair in Düsseldorf, Germany on Wednesday 20 November, operating in Hall 1 and Hall 3 to facilitate meetings and make connections with other companies in the in-vitro diagnostics field. 

Jack said: “It is very important for us to attend industry trade fairs such as Medica, in order to build relationships with other professionals and offer our services in Contract Manufacturing and Contract Research for coagulation, haemostasis, and in-vitro diagnostics. 

“We are a company that offers an interactive contract manufacturing service that partners often want. They can approach us with an idea about a new product or discuss one that is already in a stage of development. 

“It will be beneficial to Hart and important for us to meet and interact with other organisations; to demonstrate that we can capitalise on being a small and flexible company that can provide a bespoke service for our customers and their needs – that we can be their Partners in Haemostasis.” 

Alongside exhibitions from some of the world’s biggest names in electromedical equipment, laboratory technology and diagnostics, Medica, will also feature a series of lectures and symposiums such as the Health IT forum, the LabMed forum and many more that can be found here. 

Jack continued: “I would love to chat with current partners and discuss the next steps going forward, exploring any further innovations that we can build on together.  

“In recent months, we have focused on regulatory affairs and dealing with compliances and regulations, most notably ISO 13485:2016 and FDA CFR 21 – 820. We are now looking to focus on long-term partnerships and bolstering our market penetration further afield.”   

After the recent takeover of Hart Biologicals, the company is eager to find new partners in the field and will continue to increase our presence at conventions and dedicate time to follow up, meeting with the connections made at Medica. 

If you would like to get in touch with Hart Biologicals or Jack Doyle at jack.doyle@hartbio.co.uk

For any more information on Medica, please visit: https://www.medica-tradefair.com